Clinical Trial Update: A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER [Phase 2]

View source ↗

Summary

A Phase II randomized study evaluating maintenance cemiplimab versus best supportive care after first-line platinum-based chemotherapy in advanced or recurrent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• Libtayo (cemiplimab) (cemiplimab)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Penile Cancer | Phase 2 | Status: NOT_YET_RECRUITING